Skip to main content
Clinical Trials/NCT02232997
NCT02232997CompletedNot Applicable

The Optimal Hydration With Sodium Chloride in High Risk Patients Undergoing Coronary Angiography, Reduction of Risk of Contrast-associated Acute Kidney Injury After Cardiac Catheterization 2 (TIME RESCIND 2) Study

Guangdong Provincial People's Hospital1 site in 1 country1,002 target enrollmentStarted: April 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1,002
Locations
1
Primary Endpoint
Contrast-associated acute kidney injury a

Study Overview

Brief Summary

No well-defined protocols exist to guide fluid administration for prevention of contrast-associated acute kidney injury in high risk patients. The investigators will compare long term hydration at routine speed(12h before and after procedure at 1ml/kg/h) with short term hydration at high speed(1h before and 4h after procedure at 3ml/kg/h) to verify our hypothesis that the short term hydration may not be inferior to the long one.

Detailed Description

No well-defined protocols exist to guide fluid administration for prevention of contrast-associated acute kidney injury in high risk patients undergoing coronary angiography. Long term hydration at routine speed(12h before and after procedure at 1ml/kg/h), as the most recommended adequate hydration, has been carried out to prevent contrast-associated acute kidney injury in lots of clinical trials. Base on the data in the POSEIDON randomized controlled trial with hemodynamic-guided fluid administration, short term hydration at high speed(1h before and 4h after procedure at 3ml/kg/h) may not be inferior to the classic long term hydration, the speed should be reduced half of the intended speed in all the patients. We hypothesized short term hydration may not be inferior to the long one to reduced significantly the hospital stay and healthy cost.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •≥18 years of age;
  • •Written informed consent;
  • •Candidates scheduled for coronary intervention (angiography and/or coronary intervention);
  • •Patients with chronic renal insufficiency, the baseline estimated glomerular filtration rate (eGFR) was 15-60 mL/min / 1.73 m²
  • •At least one risk factor (age>75 years, medical history of diabetes mellitus or hypertension, congestive heart failure [NYHA class >II or history of acute pulmonary edema]);

Exclusion Criteria

  • •End-stage renal failure or heart/renal transplantation;
  • •History of exposure to contrast medium or acute infectious diseases within 48 hours prior to the procedure;
  • •Acute decompensated heart failure;
  • •Left ventricular thrombus;
  • •Allergy to contrast agent;
  • •Pregnancy or lactation;
  • •Malignant tumour or life expectancy <1 year;
  • •Pre-procedural receipt of NSAIDs (except Asprin), aminoglycosides, cyclosporine or cisplatin in the past 48 h;
  • •Severe valve disease or elective undergoing surgery.

Arms & Interventions

Standard Hydration

Active Comparator

Standard long-term hydration, i.e. hydrated with normal saline 12 hours before and 12 hours after coronary intervention at a rate of 1 ml/kg/h

Intervention: Standard Hydration (Other)

Simplified Hydration

Active Comparator

Rapid short-term hydration, i.e. hydrated with normal saline from 1 hour before to 4 hours after coronary intervention at a rate of 3 ml/kg/h

Intervention: Simplified Hydration (Other)

Outcomes

Primary Outcomes

Contrast-associated acute kidney injury a

Time Frame: 72 hours

Defined as ≥25% or 0.5 mg/dL absolute increase in serum creatinine from baseline during the first 48-72 hours after the procedure

Secondary Outcomes

  • Number of Participants with Acute heart failure(post-procedural during hospitalization, an average of 3 days)
  • Major adverse clinical events(1 year)
  • Length of stay(an average of 7 days)
  • Contrast-associated acute kidney injury b(72 hours)
  • Contrast-associated acute kidney injury d(48 hours)
  • Contrast-associated acute kidney injury c(24 hours)
  • Contrast-associated acute kidney injury e(24 hours)
  • Change in eGFR a(72 hours)
  • Contrast-induced persistence kidney injury(3 months)
  • Change in eGFR b(72 hours)
  • Total hospitalization costs(an average of 7 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jiyan Chen

MD

Guangdong Provincial People's Hospital

Study Sites (1)

Loading locations...

Similar Trials